ABSTRACT
INTRODUCTION
Cloves (Caryophyllus aromaticus L, or Syzygium aromaticum) are the aromatic dried flower buds of a tree belonging to the family Myrtaceae. It is native to Indonesia and used as a spice. The clove tree is an evergreen that grows to a height ranging from 10-20 meters having large oval leaves and crimson flowers in numerous groups of terminal clusters. The flower buds are at first of a pale color and gradually becoming green, after which they develop into a bright red, when they are ready for collecting. Cloves are harvested when 1.5-2 cm long, and consist of a long calyx, terminating in four spreading sepals, and four unopened petals which form a small ball in the center (Bisset, 2001) . Species of this family are often used for several medical purposes, including the treatment of gastrointestinal, due to increase hydrochloric acid in the stomach and to improve peristalsis (Kumari, 1991) , circulatory disturbances (Saeed and Gilani, 1994) and as anti-carcinogen agent (Banerjee et al., 2006) . Clove has been used in humans for dentistry applications for over two thousand years to alleviate the pain of toothache and also widely used to disinfect root canals in temporary fillings and as an oral anesthetic (Duke, 1985) . Eugenol has pronounced antiseptic and anaesthetic properties (Chaieb et al., 2007) . Other constituents of the clove are acetyl eugenol, betacaryophylline, vanillin, crategolic acid, tannins, gallotannic acid, methyl salicylate, flavanoids (eugenin, kaempferol, rhamnetin, and eugenitin), triterpenoids (oleanolic acid, stigmasterol and campesterol) and several sesquiterpenes (Kramer, 1985; Musenga et al., 2006) . Eugenol is known to inhibit the growth of bacteria and is a natural antibiotic (Suresh-Babu and Madhavi, 2001) with broad antimicrobial activities against gram-positive, gram-negative and acid fast bacteria, as well as fungi (Bisset, 1994; Lueng and Foster, 1996) . Red blood cells labeled with technetium-99m (99mTc-RBC) are widely used in clinical nuclear medicine for several important applications (Wong et al., 2004; Jin et al., 2004; Zaman et al., 2004; Artiko et al., 2004; Harel et al., 2005; Verdu et al., 2005; Olds et al., 2005) . The labeling of RBC with 99mTc has been used as assay to evaluate the properties of different chemical agents (Abreu et al., 2006; Fonseca et al., 2007) . The radiolabeling depends on the presence of a reducing agent and stannous chloride is widely utilized. This technique is easily carried out and produces a better and well-controlled product (Harbert et al., 1996; Saha, 2004) . The morphological analysis of the RBC has been of importance in the investigations of diseases (Bielory, 2004) and to evaluate the effects of natural products on membrane structures (Oliveira et al., 2003) . The aim of this work was to evaluate in vitro, the effects of clove on the labeling blood constituents with 99mTc and on the morphology of red blood cells. were triturated and 1 g of the triturate was mixed with 10ml of 0.9% NaCl solution (saline). After that, the mixture was boiled at 100 ºC and filtered through filter paper (Aldrich Chemical Co, 11 cm, Lot number k932). The filtered solution was considered 100 mg/ml of aqueous clove extract.
MATERIALS AND METHODS

Animals
Spectrophotometric measurements
A spectrophotometric analysis (Analyser, 800M, São Paulo, Brazil) of the extract at 10 mg/ml was carried out. The absorbance at 480 nm was considered the marker of the quality control of this extract. All the prepared extracts to be used in the experimental procedures had an optical density of 0.49±0.01 ( Figure 1 ).
Labeling of blood constituents with 99mTc
Samples of whole blood (0.5 ml) were incubated with 100 µl clove extract at different concentrations (0, 6.5, 12.5, 25, 50 and 100 mg/ml) for 1 hour. After that, 0.5 ml of a freshly prepared stannous chloride solution (SnCl 2 , 1.2 µg/ml, Sigma Chemical Co. St Louis, USA) was added. Then, 100 µl of 99mTc (3.7 MBq) were added and the incubation continued for another 10 minutes. These samples were centrifuged (1500 rpm, 5 minutes) and plasma (P) and blood cells (BC) were separated. Samples (20 µl) of P and BC were also precipitated with 1 ml of trichloroacetic acid (5 %) and soluble (SF) and insoluble (IF) fractions were obtained. The radioactivity (% ATI) in P, BC, IF-P, SF-P, IF-BC and SF-BC was determined in a well gamma counter (Clinigamma, gamma counter, Packard Instrument Company, mod C5002, USA). The percentage of incorporated radioactivity (% ATI) was calculated as described previously (Bernardo-Filho et al., 1986) .
Morphological evaluation
Blood samples (n=5) for each extract concentration) were incubated with clove extract at different concentrations (6.5, 12.5, 25, 50 and 100 mg/ml) for 1 hour. After that, blood smears (n=5, for each extract concentration) were prepared, dried at room temperature and stained by May-Grünwald-Giemsa method (Barcia, 2007) . Briefly, the blood smears were fixed with methanol for 5 minutes, then stained with Giemsa (azure eosin methylene blue solution) for 10 minutes and washed in water to remove excess of stain. The slides were dried at room temperature. These stained glass slides were analyzed by optical microscopy, morphometric measurements (perimeter and area) were performed by a software Image pro plus (Cibernetics, USA) to a total of five fields per each slide and the perimeter/area ratios were calculated.
Statistical analysis
Data are reported as means ± standard deviation of % ATI and perimeter/area ratio and they were compared between the treated and control group by One-way analysis of variance -ANOVA, followed by Bonferroni post test with a p<0.05 as significant level. InStat Graphpad software was used to perform statistical analysis (GraphPad InStat version 3.00 for Windows 95, GraphPad Software, San Diego, California, USA). Fig. 1 shows the absorption spectrum of the clove extract used in the experiments. The pattern of the absorption spectra presents the highest measure of the optical density (0.489±0.013) at 480 nm. This parameter has permitted to control the conditions to prepare the extracts and has been used as a marker. Table 1 shows the effect of different concentrations of the clove extract on the distribution of radioactivity between cellular and plasma compartments. The clove extract used decreased significantly (p<0.05) the % ATI on the cellular compartment from 96.96±1.06 to 44.45±2.87. Table 2 shows the effect of different concentrations of the clove extract on the fixation of 99mTc on plasma proteins. The clove extract decreased significantly (p<0.05) the fixation of the 99mTc on the plasma proteins from 64.28±7.55 to 15.11±0.63. Figs. 2 and 3 represent the photomicrographies of blood smears from blood samples treated with saline (0.9% NaCl) and clove extract at the higher concentration used (100 mg/ml), respectively. The qualitative comparison between these figures indicates that clove extract alters the morphology of RBC. 
RESULTS
DISCUSSION
Some authors have reported that nuclear medicine procedures could be altered by medication treatments that the patient is undergoing. (Hesslewood and Leung, 1994; Owunwanne et al., 1995; Sampson, 1999) . Blood constituents labeled with 99mTc have been used in several clinical examinations (Saha, 2004) and also as an experimental assay on an attempt to verify the effect of drugs ). This experimental model has permitted to obtain relevant information about properties of various chemical compounds (synthetic and natural) (Abreu et al., 2006; Fonseca et al., 2007) . The analysis of the results shown in tables 1, 2 and 3 indicates that there was an important alteration on the labeling of the blood constituents with 99m
Tc when the incubation with clove extract was made in vitro at highest concentration used. These results could be explained, at least in part, by a possible oxidant and citotoxic property of the chemical compounds that are present in the clove solution (Schmalz et al., 2000) . These compounds could oxidize the stannous ions that are necessary to the reduction of the pertechnetate ion, as suggested by other authors to several natural products, as Maytemus icilifolia (Oliveira et al., 2000) , Ginkgo biloba (Moreno et al., 2002) , Paullinia cupana (Oliveira et al., 2002) and Mentha crispa (Santos-Filho et al., 2004) . Other possible explications would be the actions of the clove on the ions transport systems and alteration of the RBC membrane structure. In fact, some flavoids were described as capable of interacting with ions transport channels in membrane (Morales et al., 1994; Re et al., 1999) . Bratel et al., (1998) have reported that extractable components of some commonly used root canal sealing materials may interfere with immunocompetent cells in vitro. In addition, the antibacterial effect of compounds presents in clove extract could be related to action on bacterial membrane. Changes in the optic disc structure and thickness of retinal nerve fiber layer in chronic ocular hypertensive monkeys (Shimazawa et al., 2006) , the relationship between infarct-related artery stenosis and capillary density (Prech et al., 2005) and the effects of two sex hormones on normal mammal gland of female rats (Pompei et al., 2005) are several important findings obtained by morphometric measurements. Oliveira et al. (2003) showed possible alterations by morphometric analysis of RBC from blood treated with natural products. The qualitative morphologic analysis indicated that clove extract induce alterations on shape of RBC (Fig. 2) . However, this finding was not confirmed by quantitative analysis by mophometric measurements indicating no effect of clove extract at the higher concentration (100 mg/ml) on the perimeter/area ratio of RBC ( Figure  3 ). The morphology of RBC is influenced by function of ion transport systems in membrane (Lew and Bookchin, 2005) . Chemical compounds in clove extract may interact with these systems and alter the morphology of RBC observed in this study. This hypothesis could be in agreement with the results of the distribution of radioactivity in cellular compartment (Table 1 ). In conclusion, the results obtained in this work indicate that the aqueous clove extract studied present chemical compounds that interfere with the labeling of blood constituents with 99mTc and alter the morphology of RBC by oxidative/chelating actions or interacting with the cellular membrane structure.
RESUMO
O cravo-da-índia (Caryophyllus aromaticus L.) tem sido usado em tratamentos clínicos. Constituintes sangüíneos marcados com tecnécio-99m (99mTc) são usados em medicina nuclear O objetivo foi avaliar os efeitos de um extrato de cravo-da-índia na marcação de constituintes sangüíneos com 99mTc e na morfologia das hemácias. Amostras de sangue foram incubadas com cravo-da-índia, cloreto estanoso e 99mTc. Plasma, células sangüíneas, frações insolúveis do plasma e das células sangüíneas foram separadas. A porcentagem de radioatividade incorporada (% ATI) nestas frações foi calculada. Forma e relação perímetro/área das hemácias foram avaliadas. O extrato de cravo-da-índia alterou significativamente (p<0,05) a radiomarcação de constituintes sangüíneos e qualitativamente a forma das hemácias. Não foram obtidas alterações na relação perímetro/área hemácias. Os resultados indicam que o extrato de cravo-da-índia apresenta compostos que interferem com a radiomarcação de constituintes sangüíneos e alteram a morfologia de células sangüíneas através de ações oxidativas/quelantes ou interagindo com a estrutura da membrana celular.
